Literature DB >> 28956072

[One size does not fit all].

S Bercker1, S Laudi2, S N Stehr2.   

Abstract

Mesh：

Substances：

Year:  2017        PMID： 28956072     DOI： 10.1007/s00101-017-0374-5

Source DB:  PubMed          Journal:  Anaesthesist        ISSN： 0003-2417            Impact factor:   1.041


× No keyword cloud information.
  6 in total

1.  A survey of knowledge, attitudes, and beliefs of house staff physicians from various specialties concerning antimicrobial use and resistance.

Authors:  Arjun Srinivasan; Xiaoyan Song; Ann Richards; Ronda Sinkowitz-Cochran; Denise Cardo; Cynthia Rand
Journal:  Arch Intern Med       Date:  2004-07-12

2.  Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock.

Authors:  Anand Kumar; Daniel Roberts; Kenneth E Wood; Bruce Light; Joseph E Parrillo; Satendra Sharma; Robert Suppes; Daniel Feinstein; Sergio Zanotti; Leo Taiberg; David Gurka; Aseem Kumar; Mary Cheang
Journal:  Crit Care Med       Date:  2006-06       Impact factor: 7.598

3.  Ventilator-associated pneumonia caused by potentially drug-resistant bacteria.

Authors:  J L Trouillet; J Chastre; A Vuagnat; M L Joly-Guillou; D Combaux; M C Dombret; C Gibert
Journal:  Am J Respir Crit Care Med       Date:  1998-02       Impact factor: 21.405

4.  Identifying critically ill patients at risk for inappropriate antibiotic therapy: a pilot study of a point-of-care decision support alert.

Authors:  Scott T Micek; Kevin M Heard; Mollie Gowan; Marin H Kollef
Journal:  Crit Care Med       Date:  2014-08       Impact factor: 7.598

5.  Antibiotics for Sepsis: Does Each Hour Really Count, or Is It Incestuous Amplification?

Authors:  Mervyn Singer
Journal:  Am J Respir Crit Care Med       Date:  2017-10-01       Impact factor: 21.405

6.  Favorable impact of a multidisciplinary antibiotic management program conducted during 7 years.

Authors:  Philip Carling; Teresa Fung; Ann Killion; Norma Terrin; Michael Barza
Journal:  Infect Control Hosp Epidemiol       Date:  2003-09       Impact factor: 3.254
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.